Innovators in Cancer Immunology: Lung Cancer | Stories | PerkinElmer
珀金埃尔默使用cookies来确保我们为您提供在我们网站上的最佳体验。 这可能包括来自第三方网站的cookies。 如果您不改变您的设置点击继续,我们会认为您同意接收本网站的cookies。 您可以随时更改您的Cookie设置。 要了解更多信息,请查看我们的Cookie政策,其中包含有关如何管理Cookie的信息。

Innovators in Cancer Immunology: Lung Cancer

June 14, 2017



David L Rimm, MD, PhD
Professor of Pathology and of Medicine (Medical Oncology);
Director of Pathology Tissue Services;
Director of Translational Pathology
Yale University, New Haven, CT

To advance the understanding of disease mechanisms in cancer, it is critical that researchers see everything a tumor has to show them. Leveraging PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions, researchers are now visualizing and measuring tumor cells and multiple immune-cell phenotypes simultaneously for the first time in formalin-fixed paraffin-embedded (FFPE) tissue.

Because of Phenoptics’ integration of multiplexed immunohistochemistry and imaging, leading scientists are now able to quantitatively capture systems biology data in cellular detail. What follows are brief profiles of some of these Innovators in Cancer Research and how they are using Phenoptics to discover new insights into the complexity of immune-cancer interactions that affect countless millions of patients around the world.

Dr. David Rimm, a pioneer of quantitative immunohistochemistry and inventor of AQUA® technology, focuses on predicting response to therapy in breast cancer and predicting recurrence or metastasis in melanoma and lung cancer. Dr. Rimm is working closely with PerkinElmer to bring rigor to the development of Phenoptics to make it a truly quantitative approach by helping to establish consistent Opal staining methods and expression measurement controls. He is particularly interested in exploring the per-cell and spatial parameters enabled by Phenoptics. Dr. Rimm’s first project evaluated Tumor Infiltrating Lymphocyte (TIL) status in a lung cancer Thrombotic Microangiopathy (TMA).

更多故事关于 成像, 生命科学, 病理研究

Innovators in Cancer Immunology: Lymphoma

Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a lymphoma cancer case study, Dr. Rodig uses t...

Innovators in Cancer Immunology: Breast Cancer

Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a breast cancer case study, Dr. Rimm uses this...